DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Captopril And Hydrochlorothiazide is a drug marketed by Cosette, Ivax Sub Teva Pharms, Mylan, Vintage Pharms Llc, and Watson Labs. and is included in five NDAs.
The generic ingredient in CAPTOPRIL AND HYDROCHLOROTHIAZIDE is captopril; hydrochlorothiazide. There are fifteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the captopril; hydrochlorothiazide profile page.
A generic version of CAPTOPRIL AND HYDROCHLOROTHIAZIDE was approved as captopril; hydrochlorothiazide by MYLAN on December 29th, 1997.
Recent Clinical Trials for CAPTOPRIL AND HYDROCHLOROTHIAZIDE
Identify potential brand extensions & 505(b)(2) entrants
|West China Hospital||Phase 4|
|Vanderbilt University Medical Center||Phase 1/Phase 2|
|VA Office of Research and Development||N/A|